Improved genetically modified Escherichia coli strain for prescreening antineoplastic agents.

Clinical experience suggests that drugs that interact with and damage DNA are useful in cancer chemotherapy (H. Umezawa , p. 43-72, in V. T. DeVita , Jr., and H. Busch [ed.], Methods in Cancer Research; Cancer Drug Development, vol. XVI, 1979). Prescreening systems for antitumor agents in natural pr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Bartus, H R, Mirabelli, C K, Auerbach, J I, Shatzman, A R, Taylor, D P, Johnson, R K, Rosenberg, M, Crooke, S T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1984
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185600/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6203484/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.5.622
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!